RYBELSUS®—All of This in 1 Pill
Get your A1C down
Once-daily RYBELSUS® is proven to significantly lower A1C, along with diet and exercise.
In a 6-month study, the majority of people taking RYBELSUS® reached an A1C of less than 7%
Results are from a 6-month medical study with 703 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with a sugar pill when both were added to diet and exercise. People who took a sugar pill had a 0.3% lowering of A1C, and 31% reached an A1C goal of <7%.
When I decided to focus on my A1C, I got DOWN with RYBELSUS®.
Troy's A1C is DOWN with RYBELSUS®.
RYBELSUS® patient shown is a paid spokesperson for Novo Nordisk.
Reaching your A1C goal is possible
The American Diabetes Association (ADA) recommends an A1C goal of less than 7% for many adults with type 2 diabetes. Your healthcare provider will tell you what goal is right for you.
If you're taking diabetes pills and still not at your A1C goal, talk to your healthcare provider to see if RYBELSUS® is right for you. Download a discussion guide to help you get started.
RYBELSUS® may help you lose some weight
RYBELSUS® is a medicine for adults with type 2 diabetes that is used along with diet and exercise to improve blood sugar and A1C. While not for weight loss, it may help you lose some weight.
In the same 6-month study, people lost around 8 pounds
These people weighed an average of 194 pounds and took 14 mg of RYBELSUS®
People who weighed an average of 196 pounds and took 7 mg of RYBELSUS® lost around 5 pounds
Results are from a 6-month medical study with 703 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with a sugar pill when both were added to diet and exercise. People who weighed an average of 195 pounds and took a sugar pill lost around 3 pounds. While many people in medical studies lost weight, some did gain weight.
RYBELSUS® and cardiovascular safety
RYBELSUS® does not increase the risk of major cardiovascular (CV) events such as heart attack, stroke, or death.
In a cardiovascular safety study, 3183 adults with type 2 diabetes and a high risk of CV events were treated once daily with either 14 mg RYBELSUS® or a sugar pill in addition to their usual diabetes and CV medications.
© 2023 Novo Nordisk All rights reserved. US22RYB01079 April 2023